What is LLY's current stock price?

As of now, LLY is trading at $1074.31, with a daily change of -0.25%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY

Eli Lilly and

$1074.31

-$2.67 | -0.25%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$1111.99

MKT CAP

$1.02T

52W Low

$623.78

VOL

$526.66K

P/E Ratio

52.54

AVG VOL

$3.60M

RSI

62.96

TREND

Uptrend

BQ Stock IQ

Login to see Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Target Price

Login to display

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Investors confidence is positive

LLY Rewards

Trading below its fair value

LLY Price Performance

$1104.34 (-2.72%)

$763 (+40.80%)

$769 (+39.70%)

$797.48 (+34.71%)

1year

6month

3month

1month

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Analysts Opinion

LLY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

94%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

91%

93%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

94%

5%

Positive

Negative

61 out of 65
events present

3 out of 65
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1071.64

Resistance
Price

$943.69

Current Price Range

$1109.94

Show methods +

Linked to LLY

IQ

Close Price

Change

NVO

4.04

52.15

-0.80%

PFE

3.72

24.98

-0.22%

SNY

3.74

48.41

+0.10%

NVS

3.87

138.69

-0.14%

MRK

4.18

106.36

-0.08%

LLY Latest Analysis +

Top Analyst Reports for Eli Lilly Shell & ICICI Bank. LLYs strong GLP-1 demand international launches and new drug contributions highlight why it leads todays top analyst reports lineup.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk. The approval gives Novo Nordisk a head start over chief rival Eli Lilly which is racing to launch its own obesity pill.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

Noteworthy Monday Option Activity: LLY ORCL GMED. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Eli Lilly (Symbol: LLY) where a total of 27989 contracts have traded so far representing approximately 2.8 million underlying shares. That amounts to about 75.2% of L

Mon Dec 22, 2025

$1076.48 | +0.52%

Momentum

BofA Maintains Buy on Eli Lilly (LLY) Expects 2027 Earnings to Fully Realize Value of Obesity Drug Launches.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

Rating

Abivax soars on report of Eli Lilly meeting French officials over possible deal.

Mon Dec 22, 2025

$1076.48 | +0.52%

Momentum

Eli Lilly (LLY) Gains Support From Daiwa and Goldman Sachs in Back-to-Back Calls. Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Long Term US Stocks to Buy Now. On December 16 Daiwa analyst Narumi Nakagiri upgraded Eli Lilly and Company (NYSE:LLY) to Buy from Neutral and set a $1230 price target on the stock. That move followed a similar call from Goldman Sachs earlier. On December [….]

Thu Dec 18, 2025

$1056.88 | +1.45%

Potential

Rating

After Wegovy Zepbound Shots This Eli Lilly Oral Pill Can Help Maintain Weight Loss. The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions leading to a surge in clinical trials for anti-obesity medications. Amid growing demand for such treatments significant advancements in drug development are increasingly focused on long-term sustainability and safety to meet the needs of individuals struggling with weight maintena

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer Diabetes and Demand for Targeted Therapies. Ottawa Dec. 18 2025 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is witnessing strong growth driven by the rising prevalence of chronic diseases such as cancer diabetes cardiovascular and neurological disorders. Valued at USD 52.59 billion in 2025 the market is expected to reach approximately USD 87.21 billion by 2035 growing at a CAGR of 5.19% b

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Eli Lillys Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study. Eli Lilly proved the worth of its obesity pill Thursday. A study showed patients who switched to orforglipron mostly kept the weight off.The post Eli Lilly'.s Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study appeared first on Investor'.s Business Daily.

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Eli Lilly Scores Another Major Win: Time to Buy?. Key PointsEli Lillys next-gen anti-obesity candidate hit it out of the park in a phase 3 study.

Thu Dec 18, 2025

$1056.88 | +1.45%

Potential

FAQ About LLY Stock Insights

What is LLY current stock price?

What are LLY stock strengths?

What is LLY Risk Level?

What is LLY market cap and volume?

What is LLY current Stock IQ?

Should I buy LLY stock right now?

Is LLY a Strong Buy right now?

What does a 'Strong Buy' rating mean for LLY?

What does a 'Strong Sell' rating mean for LLY?

What factors influence LLY's Stock IQ?

Explore our LLY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LLY Stock Strategies
Effective Risk Management

FIND US ON

Receive our LLY Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LLY

Eli Lilly and

Current Price

$1074.31

-$2.67 | -0.25%

52W High

$1111.99

MKT CAP

$1.02T

52W Low

$623.78

VOL

$526.66K

P/E Ratio

52.54

AVG VOL

$3.60M

RSI

62.96

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Investors confidence is positive

LLY Rewards

Trading below its fair value

Linked to LLY

Symbol

IQ

Close

Change

NVO

4.04

52.15

-0.80%

PFE

3.72

24.98

-0.22%

SNY

3.74

48.41

+0.10%

NVS

3.87

138.69

-0.14%

MRK

4.18

106.36

-0.08%

LLY Price Performance

$1104.34 (-2.72%)

$763 (+40.80%)

$769 (+39.70%)

$797.48 (+34.71%)

1year

6month

3month

1month

LLY Analysts Opinion

LLY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

94%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

91%

93%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

94%

5%

Positive

Negative

61 out of 65
events present

3 out of 65
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1071.64

Resistance
Price

$943.69

Current Price Range

$1109.94

Show methods +

LLY Stock IQ

Login to unlock Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Latest Analysis

Top Analyst Reports for Eli Lilly Shell & ICICI Bank. LLYs strong GLP-1 demand international launches and new drug contributions highlight why it leads todays top analyst reports lineup.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk. The approval gives Novo Nordisk a head start over chief rival Eli Lilly which is racing to launch its own obesity pill.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

Noteworthy Monday Option Activity: LLY ORCL GMED. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Eli Lilly (Symbol: LLY) where a total of 27989 contracts have traded so far representing approximately 2.8 million underlying shares. That amounts to about 75.2% of L

Mon Dec 22, 2025

$1076.48 | +0.52%

Momentum

BofA Maintains Buy on Eli Lilly (LLY) Expects 2027 Earnings to Fully Realize Value of Obesity Drug Launches.

Mon Dec 22, 2025

$1076.48 | +0.52%

Activity

Rating

Abivax soars on report of Eli Lilly meeting French officials over possible deal.

Mon Dec 22, 2025

$1076.48 | +0.52%

Momentum

Eli Lilly (LLY) Gains Support From Daiwa and Goldman Sachs in Back-to-Back Calls. Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Long Term US Stocks to Buy Now. On December 16 Daiwa analyst Narumi Nakagiri upgraded Eli Lilly and Company (NYSE:LLY) to Buy from Neutral and set a $1230 price target on the stock. That move followed a similar call from Goldman Sachs earlier. On December [….]

Thu Dec 18, 2025

$1056.88 | +1.45%

Potential

Rating

After Wegovy Zepbound Shots This Eli Lilly Oral Pill Can Help Maintain Weight Loss. The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions leading to a surge in clinical trials for anti-obesity medications. Amid growing demand for such treatments significant advancements in drug development are increasingly focused on long-term sustainability and safety to meet the needs of individuals struggling with weight maintena

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer Diabetes and Demand for Targeted Therapies. Ottawa Dec. 18 2025 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is witnessing strong growth driven by the rising prevalence of chronic diseases such as cancer diabetes cardiovascular and neurological disorders. Valued at USD 52.59 billion in 2025 the market is expected to reach approximately USD 87.21 billion by 2035 growing at a CAGR of 5.19% b

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Eli Lillys Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study. Eli Lilly proved the worth of its obesity pill Thursday. A study showed patients who switched to orforglipron mostly kept the weight off.The post Eli Lilly'.s Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study appeared first on Investor'.s Business Daily.

Thu Dec 18, 2025

$1056.88 | +1.45%

Activity

Eli Lilly Scores Another Major Win: Time to Buy?. Key PointsEli Lillys next-gen anti-obesity candidate hit it out of the park in a phase 3 study.

Thu Dec 18, 2025

$1056.88 | +1.45%

Potential

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LLY Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LLY Stock trends

LLY Stock performance

LLY Stock analysis

LLY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

LLY Stock Analysis & IQ Rating | Eli Lilly and

BQ Stock IQ

LLY Target Price

LLY Risk Level

LLY Analysts Opinion

LLY Street Sentiment

LLY Performance Sentiment

Technical Price Levels

Explore our LLY Stock insights

Receive our LLY Daily Alerts

LLY Street Sentiment

LLY Risk Level

Technical Price Levels

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

Receive our LLY Daily Alerts

LLY Alerts